Bertrand Camus
About Bertrand Camus
Bertrand Camus serves as the Head of Medical at Laboratoire Aguettant, where he has worked since 1992. He specializes in drug repurposing and has significant experience in medical affairs, particularly in preparing clinical reports for marketing authorization submissions.
Work at Laboratoire Aguettant
Bertrand Camus has served as the Head of Medical at Laboratoire Aguettant since 1992. In this role, he oversees medical affairs and is involved in strategic partnerships and collaborations through licensing-in and licensing-out activities. His responsibilities include preparing clinical reports, particularly modules 2-5, for marketing authorization submissions. Camus has contributed to the strategic direction and execution of medical strategies within the organization, leveraging his extensive experience in the field.
Education and Expertise
Bertrand Camus studied at the University of Medicine in Lyon, France, where he achieved his Doctor of Medicine (MD) degree. He has been involved in medical education since 1985, focusing on the application of medical knowledge in practical settings. His expertise lies in drug repurposing, where he specializes in identifying new uses for existing medications, contributing to innovative approaches in medical treatment.
Background
Bertrand Camus has a long-standing career in the medical field, with a focus on medical affairs and drug repurposing. His professional journey began with his medical education in Lyon, France, and has evolved over more than three decades. His role at Laboratoire Aguettant has allowed him to develop a deep understanding of the pharmaceutical industry and its regulatory requirements.
Achievements
Throughout his career, Bertrand Camus has made significant contributions to medical affairs, particularly in the area of drug repurposing. His involvement in preparing clinical reports for marketing authorization submissions has played a crucial role in advancing the company's medical strategies. His extensive experience has positioned him as a key figure in the strategic direction of medical initiatives at Laboratoire Aguettant.